Generics Armando Esguerra, President of Chira Pharmaceuticals, Philippines, explains the concept of chirality, why it is relevant and extremely important in the pharmaceutical industry, and what have been the major challenges and successes of the company since its founding. CHIRA Pharmaceuticals as a company was founded on the concept of…
Distribution Raymund Azurin of Zuellig Group, Philippines, discusses the potential opportunities in the Philippines’ emerging healthcare sector, the affect of the increasing use of health apps and electronic health records, and how they can be used as a competitive advantage in the healthcare landscape. Home to where the Zuellig Group…
MNCs Pedro Miranda Jr., General Manager of Pacific Healthcare Philippines, talks about the decision to join Pacific Healthcare in the Philippines, how the company’s diversification strategy has evolved over the past two years, and what’s in store for the company in terms of new principals and partnerships in the next five…
Generics Thelma Tobias–Go, President of the Philippine Chamber of the Pharmaceutical Industry and Scheele Laboartories, and Ed Ocampo, COO and Vice President of Scheele Laboratories, discuss the implications of the changing pharmaceutical landscape, and how far the country still remains from universal healthcare coverage. How have you seen the pharmaceutical…
Pharmaceutical Industry Jason Carroll, General Manager of Janssen Philippines, discusses what it will take to put Janssen Philippines on the map as one of the largest, most reputable pharmaceutical companies in the country, and why the Philippines will be a force to recon with in the near future in many industries, including…
Generics David Goodman, CEO of Pharmascience, describes the importance of balancing innovation with low cost products in Canada and outlines his company’s strategy for growth domestically and internationally. 2013 marks the thirtieth anniversary of Pharmascience. How does the company’s original business compare with its business today? Pharmascience was first established as…
R&D Nuno Brás, General Manager of LEO Farmacêuticos discusses the effect of the crisis on the Portuguese pharmaceutical market, how being a small privately owned company was an advantage during the crisis, and what future growth looks like for the company as well as the industry. You have had the opportunity…
Array In Taiwan, biotech is finally booming, and more and more of the companies benefitting from this boom are listing on the Gre Tai Securities Market (GTSM), built with small to medium enterprises in mind, and tailored for companies that are part of emerging industries. But are these companies overvalued, and…
City Pharmacy Mohamed Kouta, General Manager of City Pharmacy, discusses the company’s key strengths while delving into the market’s major weaknesses and how they will affect the future of City Pharmacy. City Pharmacy has been around for quite a while now. What is one of its strong points? Dr. Adbulrahman Al Mahmeed,…
Medpharma Yanoof Al-Bidh, Vice Chairman and Managing Director of Medpharma, speaks about the core successes that the family-owned business has experienced thus far and what the next phase will look like for Medpharma. Medpharma is a family-owned company with its origins in Oman. What made you choose the UAE as the…
UAE Ahmad Tabari, Managing Director of Pharmax, gives his insight into the regions major challenges, why he thinks that, regardless of the amount of money the government invests, the problem of a small talent pool in the industry will not go away quickly or easily, and Pharmax’s strategy to overcome this…
Neopharma BR Shetty, CEO of NMC Health, talks about the importance of fostering local talent—one of the biggest challenges of the region— building a company in the UAE, and where he sees the future of the company going. What did the progression and evolution of NMC Health look like, from…
See our Cookie Privacy Policy Here
